View in EDS HTML Full Text PDF Full Text

Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.

Saved in:
Bibliographic Details
Title: Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.
Authors: Boguniewicz M; University of Colorado School of Medicine, Aurora, CO, USA. boguniewiczm@njhealth.org.; Division of Allergy-Immunology, Department of Pediatrics, National Jewish Health, Denver, CO, USA. boguniewiczm@njhealth.org., Sher LD; Peninsula Research Associates, Rolling Hills Estates, CA, USA., Paller AS; Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Arkwright PD; Lydia Becker Institute of Immunology & Inflammation, University of Manchester, Manchester, UK., Yoshihara S; Department of Pediatrics, School of Medicine, Dokkyo Medical University, Tochigi, Japan., Chen Z; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Shah P; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Marco AR; Sanofi, Madrid, Spain.
Source: Advances in therapy [Adv Ther] 2024 Dec; Vol. 41 (12), pp. 4601-4616. Date of Electronic Publication: 2024 Oct 29.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39470878
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boguniewicz+M%22">Boguniewicz M</searchLink>; University of Colorado School of Medicine, Aurora, CO, USA. boguniewiczm@njhealth.org.; Division of Allergy-Immunology, Department of Pediatrics, National Jewish Health, Denver, CO, USA. boguniewiczm@njhealth.org.<br /><searchLink fieldCode="AU" term="%22Sher+LD%22">Sher LD</searchLink>; Peninsula Research Associates, Rolling Hills Estates, CA, USA.<br /><searchLink fieldCode="AU" term="%22Paller+AS%22">Paller AS</searchLink>; Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Arkwright+PD%22">Arkwright PD</searchLink>; Lydia Becker Institute of Immunology & Inflammation, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Yoshihara+S%22">Yoshihara S</searchLink>; Department of Pediatrics, School of Medicine, Dokkyo Medical University, Tochigi, Japan.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Shah+P%22">Shah P</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Marco+AR%22">Marco AR</searchLink>; Sanofi, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2024 Dec; Vol. 41 (12), pp. 4601-4616. <i>Date of Electronic Publication: </i>2024 Oct 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39470878
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-024-02998-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4601
    Titles:
      – TitleFull: Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boguniewicz M
      – PersonEntity:
          Name:
            NameFull: Sher LD
      – PersonEntity:
          Name:
            NameFull: Paller AS
      – PersonEntity:
          Name:
            NameFull: Arkwright PD
      – PersonEntity:
          Name:
            NameFull: Yoshihara S
      – PersonEntity:
          Name:
            NameFull: Chen Z
      – PersonEntity:
          Name:
            NameFull: Shah P
      – PersonEntity:
          Name:
            NameFull: Marco AR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 41
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1